These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 21951283)

  • 1. 3-O-methylfunicone, from Penicillium pinophilum, is a selective inhibitor of breast cancer stem cells.
    Buommino E; Tirino V; De Filippis A; Silvestri F; Nicoletti R; Ciavatta ML; Pirozzi G; Tufano MA
    Cell Prolif; 2011 Oct; 44(5):401-9. PubMed ID: 21951283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3-O-methylfunicone, a metabolite of Penicillium pinophilum, inhibits proliferation of human melanoma cells by causing G(2) + M arrest and inducing apoptosis.
    Baroni A; De Luca A; De Filippis A; Petrazzuolo M; Manente L; Nicoletti R; Tufano MA; Buommino E
    Cell Prolif; 2009 Aug; 42(4):541-53. PubMed ID: 19486013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3-O-methylfunicone produced by penicillium pinophilum affects cell motility of breast cancer cells, downregulating alphavbeta5 integrin and inhibiting metalloproteinase-9 secretion.
    Buommino E; Boccellino M; De Filippis A; Petrazzuolo M; Cozza V; Nicoletti R; Ciavatta ML; Quagliuolo L; Tufano MA
    Mol Carcinog; 2007 Nov; 46(11):930-40. PubMed ID: 17562555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Tricostantin A inhibits self-renewal of breast cancer stem cells in vitro].
    Peng L; Li FX; Shao WF; Xiong JB
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Oct; 33(10):1421-6. PubMed ID: 24144739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-growth and migration inhibition of human mesothelioma cells induced by 3-O-methylfunicone from Penicillium pinophilum and cisplatin.
    Buommino E; De Filippis A; Nicoletti R; Menegozzo M; Menegozzo S; Ciavatta ML; Rizzo A; Brancato V; Tufano MA; Donnarumma G
    Invest New Drugs; 2012 Aug; 30(4):1343-51. PubMed ID: 21656164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the stemness potency of
    Yousefnia S; Ghaedi K; Seyed Forootan F; Nasr Esfahani MH
    Tumour Biol; 2019 Aug; 41(8):1010428319869101. PubMed ID: 31423948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-metastasis activity of curcumin against breast cancer via the inhibition of stem cell-like properties and EMT.
    Hu C; Li M; Guo T; Wang S; Huang W; Yang K; Liao Z; Wang J; Zhang F; Wang H
    Phytomedicine; 2019 May; 58():152740. PubMed ID: 31005718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A recombinant protein TmSm(T34A) can inhibit proliferation and proapoptosis to breast cancer stem cells(BCSCs) by down-regulating the expression of Cyclin D1.
    Ma X; Zhang Y; Kang Y; Li L; Zheng W
    Biomed Pharmacother; 2016 Dec; 84():373-381. PubMed ID: 27668537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin D compounds reduce mammosphere formation and decrease expression of putative stem cell markers in breast cancer.
    Wahler J; So JY; Cheng LC; Maehr H; Uskokovic M; Suh N
    J Steroid Biochem Mol Biol; 2015 Apr; 148():148-55. PubMed ID: 25445919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ABCG2, a novel antigen to sort luminal progenitors of BRCA1- breast cancer cells.
    Leccia F; Del Vecchio L; Mariotti E; Di Noto R; Morel AP; Puisieux A; Salvatore F; Ansieau S
    Mol Cancer; 2014 Sep; 13():213. PubMed ID: 25216750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Senescence evasion by MCF-7 human breast tumor-initiating cells.
    Karimi-Busheri F; Rasouli-Nia A; Mackey JR; Weinfeld M
    Breast Cancer Res; 2010; 12(3):R31. PubMed ID: 20525204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3-O-Methylfunicone, a metabolite produced by Penicillium pinophilum, modulates ERK1/2 activity, affecting cell motility of human mesothelioma cells.
    Buommino E; Paoletti I; De Filippis A; Nicoletti R; Ciavatta ML; Menegozzo S; Menegozzo M; Tufano MA
    Cell Prolif; 2010 Apr; 43(2):114-23. PubMed ID: 20447056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD44hiCD24lo mammosphere-forming cells from primary breast cancer display resistance to multiple chemotherapeutic drugs.
    Ji P; Zhang Y; Wang SJ; Ge HL; Zhao GP; Xu YC; Wang Y
    Oncol Rep; 2016 Jun; 35(6):3293-302. PubMed ID: 27109463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged drug selection of breast cancer cells and enrichment of cancer stem cell characteristics.
    Calcagno AM; Salcido CD; Gillet JP; Wu CP; Fostel JM; Mumau MD; Gottesman MM; Varticovski L; Ambudkar SV
    J Natl Cancer Inst; 2010 Nov; 102(21):1637-52. PubMed ID: 20935265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-200c suppresses stemness and increases cellular sensitivity to trastuzumab in HER2+ breast cancer.
    Tang H; Song C; Ye F; Gao G; Ou X; Zhang L; Xie X; Xie X
    J Cell Mol Med; 2019 Dec; 23(12):8114-8127. PubMed ID: 31599500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AhR ligand Aminoflavone inhibits α6-integrin expression and breast cancer sphere-initiating capacity.
    Brantley E; Callero MA; Berardi DE; Campbell P; Rowland L; Zylstra D; Amis L; Yee M; Simian M; Todaro L; Loaiza-Perez AI; Soto U
    Cancer Lett; 2016 Jun; 376(1):53-61. PubMed ID: 26996297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Influence factors on the formation of mammospheres from breast cancer stem cells].
    Huang MZ; Zhang FC; Zhang YY
    Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Oct; 40(5):500-4. PubMed ID: 18931713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroR-760 suppresses cancer stem cell subpopulation and breast cancer cell proliferation and metastasis: By down-regulating NANOG.
    Han ML; Wang F; Gu YT; Pei XH; Ge X; Guo GC; Li L; Duan X; Zhu MZ; Wang YM
    Biomed Pharmacother; 2016 May; 80():304-310. PubMed ID: 27133070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation of vitamin D receptor in mammospheres: implications for vitamin D resistance in breast cancer and potential for combination therapy.
    Pervin S; Hewison M; Braga M; Tran L; Chun R; Karam A; Chaudhuri G; Norris K; Singh R
    PLoS One; 2013; 8(1):e53287. PubMed ID: 23341935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting treatment-resistant breast cancer stem cells with FKBPL and its peptide derivative, AD-01, via the CD44 pathway.
    McClements L; Yakkundi A; Papaspyropoulos A; Harrison H; Ablett MP; Jithesh PV; McKeen HD; Bennett R; Donley C; Kissenpfennig A; McIntosh S; McCarthy HO; O'Neill E; Clarke RB; Robson T
    Clin Cancer Res; 2013 Jul; 19(14):3881-93. PubMed ID: 23741069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.